These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14989201)

  • 21. Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial.
    Ide F; Nakamura T; Tomizawa M; Kawana-Tachikawa A; Odawara T; Hosoya N; Iwamoto A
    J Med Virol; 2006 Jun; 78(6):711-8. PubMed ID: 16628588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4 lymphocyte percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisited.
    Goicoechea M; Haubrich R
    J Infect Dis; 2005 Sep; 192(6):945-7. PubMed ID: 16107944
    [No Abstract]   [Full Text] [Related]  

  • 23. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4(+) cell count increase predicts clinical benefits in patients with advanced HIV disease and persistent viremia after 1 year of combination antiretroviral therapy.
    Loutfy MR; Walmsley SL; Mullin CM; Perez G; Neaton JD; ;
    J Infect Dis; 2005 Oct; 192(8):1407-11. PubMed ID: 16170758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy.
    Ferraris L; Bellistri GM; Pegorer V; Tincati C; Meroni L; Galli M; Monforte Ad; Gori A; Marchetti G
    Clin Infect Dis; 2008 Jan; 46(1):149-50. PubMed ID: 18171234
    [No Abstract]   [Full Text] [Related]  

  • 26. Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model.
    Chu H; Gange SJ; Yamashita TE; Hoover DR; Chmiel JS; Margolick JB; Jacobson LP
    Am J Epidemiol; 2005 Oct; 162(8):787-97. PubMed ID: 16135508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic vaccination for HIV disease.
    Laurence J; Johnston R
    AIDS Read; 2003 Jun; 13(6):252-3, 260. PubMed ID: 12846168
    [No Abstract]   [Full Text] [Related]  

  • 28. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.
    Marchetti G; Bellistrì GM; Borghi E; Tincati C; Ferramosca S; La Francesca M; Morace G; Gori A; Monforte AD
    AIDS; 2008 Oct; 22(15):2035-8. PubMed ID: 18784466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of highly active antiretroviral therapy in advanced AIDS with CD4 < 50 cells/mm3 in a resource-limited setting: efficacy and tolerability.
    Sungkanuparph S; Kiertiburanakul S; Manosuthi W; Kiatatchasai W; Vibhagool A
    Int J STD AIDS; 2005 Mar; 16(3):243-6. PubMed ID: 15829026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccines for HIV--Remune returns.
    TreatmentUpdate; 2004 Oct; 16(6):3. PubMed ID: 17219678
    [No Abstract]   [Full Text] [Related]  

  • 31. Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals.
    Lévy Y; Durier C; Lascaux AS; Meiffrédy V; Gahéry-Ségard H; Goujard C; Rouzioux C; Resch M; Guillet JG; Kazatchkine M; Delfraissy JF; Aboulker JP;
    AIDS; 2006 Feb; 20(3):405-13. PubMed ID: 16439874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of total lymphocyte count (TLC) as an independent criterion for initiating HAART in resource-poor countries.
    Lee SS; Wong KH
    J Infect; 2005 Jan; 50(1):66-7. PubMed ID: 15603843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation analysis on total lymphocyte count and CD4 count of HIV-infected patients.
    Liu FR; Guo F; Ye JJ; Xiong CF; Zhou PL; Yin JG; Ye LX
    Int J Clin Pract; 2008 Jun; 62(6):955-60. PubMed ID: 17983435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-based therapy shows promise.
    AIDS Patient Care STDS; 2005 Jun; 19(6):415. PubMed ID: 16041868
    [No Abstract]   [Full Text] [Related]  

  • 35. [HIV infection: in the HAART era, CD4 makes the difference].
    Varsky C
    Acta Gastroenterol Latinoam; 2004; 34(3):117-9. PubMed ID: 15742925
    [No Abstract]   [Full Text] [Related]  

  • 36. CD4+ cell-count-guided treatment interruptions in chronic HIV-infected patients with good response to highly active antiretroviral therapy.
    Boschi A; Tinelli C; Ortolani P; Moscatelli G; Morigi G; Arlotti M
    AIDS; 2004 Dec; 18(18):2381-9. PubMed ID: 15622314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HIV infection--current challenges].
    Salzberger B; Fätkenheuer G; Diehl V
    Internist (Berl); 2003 Jun; 44(6):675-7. PubMed ID: 14567103
    [No Abstract]   [Full Text] [Related]  

  • 39. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.